WEDNESDAY, July 9, 2025 (HealthDay News) — A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care for some of the most vulnerable children. The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic, The Washington Post reported. […]
The post First Malaria Drug Approved for Newborns and Small Babies first appeared on Physician’s Weekly.